Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Augmedix, Inc.

Augmedix, Inc. (AUGX) Stock Overview

Explore Augmedix, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AUGX●NASDAQ
HealthcareMedical - Healthcare Information Services
$2.35
$0.005(0.21%)
U.S. Market opens in 63h 24m

Augmedix, Inc. (AUGX)

Meyka AI Score

Z

Key Financials

Market Cap115.9M
P/E Ratio-5.33
EPS (TTM)$-0.47
ROE-1.55%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$3.40

AUGX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Augmedix, Inc. (NASDAQ: AUGX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Augmedix, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AUGX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $3.40 for the NASDAQ listing.

Key metrics behind Augmedix, Inc.'s NASDAQ-traded stock include a P/E ratio of -5.33 and a market capitalization of 115.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AUGX on the NASDAQ.

Price Performance (NASDAQ: AUGX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.21%
3-Month Change
3.30%
6-Month Change
-13.47%
Year-to-Date (YTD) Change
-59.78%
1-Year Change
-46.70%
3-Year Change
-40.03%
5-Year Change
-53.10%
All-Time (Max) Change
-53.10%

Contact Information

https://www.augmedix.com
888 669 4885
111 Sutter Street, San Francisco, CA, 94104

Company Facts

14,300 Employees
IPO DateMar 31, 2021
CountryUS

Frequently Asked Questions